Please join us for the 2024 Cellarity medSCAI Symposium: Medicines, Single Cell and AI

October 22, 2024
11:00AM – 6:00PM

Register Now

"*" indicates required fields

The Theme of this Year’s Symposium is AI Powered Drug Discovery from Data to Clinic

The field has seen tremendous progress in single cell technologies, big data and AI-driven analyses, and there has been widespread adoption of these approaches in biotech and pharma. Despite this tremendous potential, translational impact has been to date been modest. We will address this with presentations and discussions aimed at defining these limitations, finding ways to overcome them and ultimately to maximizing delivery of new drugs to patients.

Agenda

11:00AM

Registration, Welcome, and Lunch

11:30AM

Keynote Address

Aviv Regev, EVP and Head of Genentech Research and Early Development, “From Cell Atlases to Medicines with AI”

12:45PM

Session 1: From Data to New Biology

Paul Blainey, Professor, MIT Dept of Biological Engineering, “Scaling up empirical cell biology in the age of computers”
Joey Azofeifa, CEO, Arpeggio Biosciences, “Massively high throughput transcriptomics discovers a molecular glue degrading NRF2 in lung cancer”
Cole Trapnell, Professor, University of Washington, “Extracting mechanistic insights from atlas-scale single-cell perturbation experiments”

2:30PM

Session 2: From Biology and Computation to Translation

Caroline Gubser-Keller, Global Head Data Science, Novartis Institutes for BioMedical Research, “Harnessing AI for Drug Discovery to Accelerate, Enhance, and Innovate”
Mark Murcko, Dewpoint Therapeutics, “The Evolving Role of Computation in Drug Discovery”

4:00PM

Panel discussion: Identifying and Solving the Hard Challenges to Realizing the Full Translational Impact of AI on Drug Discovery/Development

Panel will be led by Ryan Cross, Endpoints News
Jen Nwankwo, Founder & CEO, 1910 Genetics
Rory Kelleher, Senior Director and Global Head of Business Development, Healthcare and Life Sciences, NVIDIA
Peter Clark, VP Computation Drug Design, Novo Nordisk
Cameron Trenor, SVP and Head of Translational Medicine, Cellarity

5:00PM

Networking cocktail hour